Ferd acquires 33% of the diagnostics company Aidian

The Finnish company Aidian develops, manufactures and sells medical instruments and tests that are used in, among other things, the primary health service to provide fast and reliable results. Aidian’s range of tests addresses several global health issues such as antimicrobial resistance (AMR), diabetes and colon cancer. One of their foremost priority areas are tests aimed at reducing unnecessary prescribing of antibiotics, which drives the growing threat of antimicrobial resistance and antibiotic-resistant bacteria.

Click here to read the press release

Buyer – FERD AS
Seller – Nordstjernan Aktiebolag
Subscribe to our Newsletter

Bridgepoint Advisers has agreed to acquire Alpha FMC

June 20, 2024

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Bridgepoint Advisers to make an offer for Alpha Financial

June 20, 2024

Bridgepoint Group Limited, the UK based private equity firm, through its UK based indirect subsidiary Actium Bidco (UK) Limited, has …

Read More →

Wakeo acquires Veroo Software

June 20, 2024

Wakeo, the France based provider of a SaaS platform providing real-time visibility on international transport flows (sea, air, road) to …

Read More →

Bregal Unternehmerkapital to acquire a majority stake in Relatech S.p.A.

June 20, 2024

Bregal Unternehmerkapital GmbH, the Germany based private equity firm, through Gemini BidCo, a special purpose vehicle indirectly controlled by the …

Read More →

DeepForm raises GBP 2m

June 19, 2024

DeepForm Limited, the UK based company, that specializes in developing and offering novel press tool designs, which help reduce material …

Read More →

PINOVA Capital invests in NEUROMEDEX

June 19, 2024

Neuromedex, the Germany based provider of disposable products for neurosurgery and intensive care, has been acquired by Pinova Capital GmbH, …

Read More →
Load More
close-link
close-link